Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|August 31, 2014
ASK1 pharmacophore model derived from diverse classes of inhibitorsSergiy A Starosyla, Galyna P Volynets, Volodymyr G Bdzhola, et al.
Bioorganic & Medicinal Chemistry|April 18, 2015
Identification of apoptosis signal-regulating kinase 1 (ASK1) inhibitors among the derivatives of benzothiazol-2-yl-3-hydroxy-5-phenyl-1,5-dihydro-pyrrol-2-oneSergiy A Starosyla, Galyna P Volynets, Sergiy S Lukashov, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 4, 2016
Design, synthesis and evaluation of 3-quinoline carboxylic acids as new inhibitors of protein kinase CK2Anatolii R Syniugin, Olga V Ostrynska, Maksym O Chekanov, et al.
Journal of Computer-Aided Molecular Design|November 7, 2019
Dual-targeted hit identification using pharmacophore screeningGalyna P Volynets, Sergiy A Starosyla, Mariia Yu Rybak, et al.
The Journal of Antibiotics|January 22, 2019
Benzaldehyde thiosemicarbazone derivatives against replicating and nonreplicating Mycobacterium tuberculosisGalyna P Volynets, Michail A Tukalo, Volodymyr G Bdzhola, et al.
Molecular Diversity|May 31, 2018
Dihydrobenzo[4,5]imidazo[1,2-a]pyrimidine-4-ones as a new class of CK2 inhibitorsMykola V Protopopov, Olga V Ostrynska, Sergiy A Starosyla, et al.
Medchemcomm|March 25, 2020
Dual-target inhibitors of mycobacterial aminoacyl-tRNA synthetases among N-benzylidene-N'-thiazol-2-yl-hydrazinesOksana P Kovalenko, Galyna P Volynets, Mariia Yu Rybak, et al.
Structural Chemistry|October 17, 2022
Pharmacophore modeling, docking and molecular dynamics simulation for identification of novel human protein kinase C beta (PKCβ) inhibitorsSergiy A Starosyla, Galyna P Volynets, Mykola V Protopopov, et al.
Bioorganic & Medicinal Chemistry|January 30, 2016
Discovery of potent anti-tuberculosis agents targeting leucyl-tRNA synthetaseOlga I Gudzera, Andriy G Golub, Volodymyr G Bdzhola, et al.
Pageof 2